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Abbreviations 27 
 28 
AdipoQ: adiponectin  29 
ACOX1: Peroxisomal acyl-coenzyme A oxidase 1 30 
CD36: fatty acid translocase 31 
ChIP: Chromatin immunoprecipitation 32 
C/EBPCCAAT/enhancer binding protein alpha 33 
DNMT: DNA methyltransferase  34 
DOHaD: Developmental Origin of Health and Disease  35 
DGAT2: diglyceride acyltransferase 36 
FABP4: fatty acid binding protein 4 37 
FAS: fatty acid synthase  38 
GC: glucocorticoid  39 
GLUT4: Glucose transporter type 4 40 
HAT: histone acetyltransferase 41 
HDAC: histone deacetylase  42 
KAT2: lysine acetyltransferase 2A 43 
LPL: lipoprotein lipase 44 
MBD: methyl-binding domain  45 
5hmC: 5-hydroxymethylcytosine  46 
5mC: 5-methylcytosine  47 
MECP2: methyl CpG binding protein 2 48 
P300: histone acetyltransferase P300 49 
PGC1-: PPAR coactivator 1-  50 
PND: postnatal days 51 
PPARperoxisome proliferator-activated receptor 52 
SIRT1: sirtuine 1 53 
SREBP1: sterol regulatory element-binding protein 1 54 
TET: Ten-eleven translocation methylcytosine dioxygenase  55 
WAT: white adipose tissue 56 
iWAT: subcutaneous inguinal  57 
pWAT: visceral perirenal 58 
SVF: stromal vascular fraction  59 
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Abstract  65 
According to the Developmental Origin of Health and Disease (DOHaD) concept, 66 
maternal obesity and accelerated growth in neonates program obesity later in life. White 67 
adipose tissue (WAT) has been the focus of developmental programming events, although 68 
underlying mechanisms remain elusive. In rodents, WAT development primarily occurs 69 
during lactation. We previously reported that adult rat offspring from high-fat diet-fed dams 70 
(called HF) showed fat accumulation and decreased PPAR mRNA levels in WAT. We 71 
hypothesized that PPAR downregulation occurs via epigenetic malprogramming which takes 72 
place during adipogenesis. We therefore examined epigenetic modifications in the PPAR1 73 
and PPAR2 promoters in perirenal (pWAT) and inguinal (iWAT) fat pads of HF offspring at 74 
weaning (postnatal days 21 (PND21) and in adulthood. PND21 is a period characterized by 75 
active epigenomic remodeling in the PPARγ2 promoter (DNA hypermethylation and 76 
depletion in active histone modification H3ac and H3K4me3) in pWAT, consistent with 77 
increased DNMT and DNA methylation activities. Adult HF offspring exhibited sustained 78 
hypermethylation and histone modification H3ac of the PPARγ2 promoter in both deposits, 79 
correlated with persistent decreased PPARγ2 mRNA levels. Consistent with the DOHaD 80 
hypothesis, retained epigenetic marks provide a mechanistic basis for the cellular “memory” 81 
linking maternal obesity to a predisposition for later adiposity. 82 
 83 
Key words: perinatal programming, Developmental Origin of Health and Disease, epigenetic 84 
mechanisms, gene expression, fat expansion. 85 
 86 
 87 
 88 
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Introduction 89 
Epidemiological studies demonstrated that adult-onset metabolic disorders may 90 
originate from events taking place during fetal and postnatal development (1). These 91 
observations led to the Developmental Origin of Health and Disease (DOHaD) hypothesis 92 
also called “developmental programming” (1). In particular, maternal obesity and accelerated 93 
growth in neonates program obesity later in life. Numerous studies confirmed that maternal 94 
obesity is correlated with increased offspring's adiposity in rodents (2–7) and in human 95 
neonates (8). Thus, white adipose tissue (WAT) has been the focus of developmental 96 
programming events in a sex- and depot-specific manner (2). In rodents, adipose tissue 97 
development occurs mainly during lactation (9–11), although adipose tissue remains to some 98 
extent expandable throughout life (12, 13). Adipocyte progenitors are highly sensitive to 99 
maternal factors. Suboptimal nutritional and hormonal milieu during the perinatal period may 100 
affect adipogenesis, resulting in modified growth and persistent changes in the structure and 101 
function of WAT (14–16).  102 
However, the mechanisms underlying developmental programming are poorly 103 
understood. Because the consequences of the events occurring in early life are maintained 104 
throughout adult life, epigenetic modifications are likely to play an important role in this 105 
process (17). Epigenetics is defined as heritable changes in gene expression that do not 106 
involve changes to the underlying DNA sequence. Epigenetics relate to chromatin 107 
modifications, including DNA methylation and histone modifications (18). DNA methylation 108 
results from the transfer by DNA methyltransferase (DNMT) of a methyl group to the 109 
cytosine residue within CpG dinucleotides to form 5-methylcytosine (5mC) and serves to 110 
establish gene silencing (19). 5mC both positively and negatively modulates binding of 111 
numerous DNA binding proteins including methyl-binding domain (MBD) proteins (MBD2, 112 
MeCP2). MBD can recruit protein and chromatin remodeling complexes known to promote 113 
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the formation of a condensed chromatin structure (20). 5-hydroxymethylcytosine (5hmC) is 114 
another important cytosine modification catalyzed by the enzymes of the Ten-eleven 115 
translocation methylcytosine dioxygenase (TET) family that serves as an intermediate for 116 
demethylation. It can also promote chromatin opening at transcriptional regulatory regions 117 
(21). Chromatin structure and accessibility are also controlled by histone posttranslational 118 
modifications (18). For example, acetylation of histone H3 lysine residues (H3ac) and 119 
methylation of H3K4 (H3K4me3) are associated with active transcription while methylation 120 
of H3K9 (H3K9me3) generally indicates silenced chromatin (18). These histone 121 
posttranslational modifications are catalyzed by various enzymes including histone 122 
acetyltransferase (HAT) such as KAT2 and P300 as well as histone deacetylase (HDAC) such 123 
as SIRT1. Histone-modifying enzyme activity is dependent on intermediary metabolites and 124 
hormonal responses (22). Editing of epigenetic marks during critical developmental windows 125 
in early life may serve as a memory of exposure to potential environment insults (1). The 126 
persistence of these marks throughout life may program permanent changes in gene 127 
expression (1). 128 
We previously showed that adult male rat offspring from high-fat diet-fed dams (called 129 
HF) displayed higher adiposity (2), hyperleptinemia and elevated leptin gene expression in 130 
WAT (25). Persistent leptin upregulation occurs via epigenetic malprogramming during 131 
lactation in a depot-specific manner (23). We also showed that adult HF offspring exhibited a 132 
decrease in PPAR gene expression in perirenal (pWAT) fat pad (2). PPARis considered the 133 
master regulator of adipose tissue promoting all processes involved in adipocyte function and 134 
WAT expansion. PPAR is present in two isoforms, PPAR1 and PPAR2, generated by 135 
alternative promoter usage (24). PPAR1 is expressed at low level in many cell types 136 
including cells from stromal vascular fraction (SVF) of adipose tissue, whereas the expression 137 
of PPAR2 is mainly restricted to adipocyte (24). Although several studies reported 138 
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dysregulation of PPAR expression in offspring from obese dams (3–5, 7, 25, 26), scarce data 139 
is available about programming mechanisms.  140 
Here, we hypothesized that maternal obesity programs persistent PPARγ 141 
downregulation in HF offspring via epigenetic mechanisms malprogramming which take 142 
places during WAT development. Thus, we examined epigenetic modifications (i.e., DNA 143 
and histone modifications) focusing on both PPARγ promoters as well as activity and 144 
expression of chromatin modifying enzymes in pWAT and inguinal (iWAT) fat pads of HF 145 
offspring at weaning and 9 months of age. 146 
 147 
Materials and methods 148 
 149 
Animals 150 
 Animal use accreditation by the French Ministry of Agriculture (No. 04860) has been 151 
granted to our laboratory for experimentation with rats. Experiments were conducted in 152 
accordance with the principles of laboratory animal care (European Communities Council 153 
Directive of 1986, 86/609/EEC) as previously described (2, 25). One-month-old virgin female 154 
Wistar rats were purchased from Charles River Laboratories (L’Arbresle, France) and were 155 
housed in individual cages in a humidity-controlled room with a 12:12-h light-dark cycle. 156 
Food and water were available ad libitum. After two weeks of acclimatization on a control (C) 157 
diet (3.85 kcal/g with 10% of total calories as fat consisting of soybean oil (5.6%) and lard 158 
(4.4%), 70% as carbohydrate and 20% as protein; D12450J, Research Diets, New Brunswick, 159 
NJ, USA), female rats were fed either a high-fat (HF) diet (5.24 kcal/g with 60% of total 160 
calories as fat consisting of soybean oil (5.6%) and lard (54.4%), 20% as carbohydrate and 161 
20% as protein; D12492B, Research Diets, New Brunswick, NJ, USA) or a C diet for 16 162 
weeks (n=30 per group). After mating with a male rat fed a C diet, 22-week-old pregnant 163 
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females were transferred into individual cages with free access to water and to their respective 164 
diets (C or HF diet) throughout gestation and lactation. At parturition, pups were weighed and 165 
sexed. Litter size was adjusted to 8 pups per dam (four males and four females). Body weight 166 
of pups was assessed on postnatal days 21 (PND21). Only male offspring have been used for 167 
further analysis. After weaning, male offspring from C or HF dams were housed individually 168 
with free access to water and C diet. Body weight of animals was measured weekly until 9 169 
months of age. Male offspring were sacrificed at 2 different stages: PND21 and 9 months of 170 
age (n=10 from C or HF dams). To obviate any litter effects, animals used for each 171 
experiment were randomly chosen in different litters and only a limited number of animals 172 
(n= 1 to 2) was used from each litter.  173 
 174 
Plasma and tissue collections 175 
 21-day-old male neonates were separated from their dams and 9-month-old (9M) male 176 
rats were
 
fasted 16 hours before they were sacrificed by decapitation (between 9 and 10 a.m.). 177 
Trunk blood samples were collected into prechilled tubes containing EDTA (20 μl of a 5% 178 
solution) and centrifuged at 4000 g for 10 min at 4°C. Plasma was stored at −20°C. Fat pads 179 
were weighed, frozen in liquid nitrogen and stored at -80°C.  180 
 181 
Quantification of endocrine parameters  182 
 Plasma hormone levels were evaluated in PND21 and 9M male offspring. Blood 183 
glucose was determined using a glucometer (Glucotrend 2; Roche Diagnostics, France). 184 
Plasma corticosterone levels were determined by a competitive enzyme immunoassay 185 
(Immunodiagnostic Systems Ltd, Boldon, U.K). Plasma insulin concentrations were measured 186 
by ELISA (DRG, Internatlukaional, Inc. USA). The assay sensitivity was 0.07 ng/ml 187 
(insulin), 0.55 ng/ml (corticosterone) and the intra-and inter-assay coefficients of variation 188 
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were 4% and 9.1% (insulin), 4.9% and 7.8% (corticosterone), respectively. Assay kits were 189 
applied to determine the contents of plasma triglycerides (61238 Triglyceride Enzymatique 190 
PAP100). 191 
 192 
Western blot analysis 193 
Immunoblotting analysis were carried out as described previously (23). Monoclonal 194 
mouse antibody against PPAR (catalogue no. sc-7273) was purchased from Santa Cruz 195 
Biotech (Dallas, TX, USA) and was diluted 1:200. Actin antibody (catalogue no. A2228) was 196 
purchased from Sigma Aldrich (Saint Quentin Fallavier, France) and was diluted 1:1000. 197 
Anti-mouse IgG, HRP-linked Antibody (catalogue no. 7076) secondary antibodies were 198 
purchased from Cell Signalling (Danvers, MA, USA) and were diluted 1:10,000.  199 
 200 
Pyrosequencing analysis 201 
 Genomic DNA was extracted from frozen WAT using a DNA extraction kit (DNeasy 202 
blood and tissue kit, Qiagen, Courtaboeuf, France) and modified with sodium bisulfite using 203 
the EpiTect Fast Bisulfite Conversion kit (Qiagen, Courtaboeuf, France) according to the 204 
manufacturer’s protocol. The percentage of cytosine methylation was determined by 205 
pyrosequencing bisulfite converted DNA using Pyro-Mark Q24 (Qiagen, Courtaboeuf, 206 
France). Pyrosequencing primers were designed to amplify PPARand PPARCpG sites 207 
(Table 1). PCR was performed with 20 l final reaction volumes with 1.5 ml of bisulfite DNA 208 
(10 ng), 10 l of QuantiTect EurobioGreen PCR Mix Hi-ROX (Eurobio, Les Ulis, France), 209 
7.7 l of H2O, and 0.4 l of each primer set (10 mM). Sequencing reactions used 10 l of 210 
PCR product and 20 l of 0.375 mM sequencing primer (Qiagen, Courtaboeuf, France). 211 
Pyrosequencing assays were validated with a DNA methylation scale (0%, 5%, 25%, 50%, 212 
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75% and 100%) (EpigenDX, Hopkinton, USA). Each assay included a bisulfite conversion 213 
check to verify full conversion of the DNA. 214 
 215 
Chromatin immunoprecipitation 216 
 ChIP assays were performed as previously described (27) with antibodies against 217 
H3K4me3, H3ac and H3K9me3 (Abcam, Cambridge, UK, ab8580, ab47915 and ab1773) and 218 
IgG (Cell Signaling Technology, Danvers, USA, #2729) as a negative control. H3ac, 219 
H3K4me3 and H3K9me3 levels were analyzed using immunoprecipitated and input DNA as 220 
control. 221 
 222 
RNA isolation and real-time PCR 223 
PPARγ isoforms (PPARγ1, PPARγ2), PPARγ targets (C/EBP, SREBP1, FAS, 224 
DGAT2, LPL, CD36, FABP4, GLUT4, ACOX1, AdipoQ, Resistin), enzymes of the 225 
epigenetic machinery (DNMT1, MBD2, MECP2, TET2, TET3, KAT2, P300, HDAC1, 226 
SIRT1, LSD1, SUV39) mRNA levels were determined by RT-qPCR using SyberGreen-based 227 
chemistry as previously described (2). Cyclophilin A (PpiA) and Ribosomal Protein Lateral 228 
Stalk Subunit P1 (RPLP1) were used as reference genes for RT-qPCR. Primer sequences are 229 
listed in Table 1. 230 
 231 
Global DNA methylation and hydroxymethylation  232 
Relative levels of global DNA methylation were assessed by me-CpG ELISA using 233 
the MethylFlashTM Methylated DNA Quantification Kit (Cat # P-1034; Epigentek, 234 
Mundolsheim, France). Global DNA hydroxymethylation were measured using the Quest 5-235 
hmC™ DNA ELISA Kit (Zymo Research, Irvine, CA, USA) according to manufacturer’s 236 
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instructions. The amount of DNA methylation and DNA hydroxymethylation was calculated 237 
based on a standard curve generated using the kit controls. 238 
 239 
Enzyme activity 240 
DNMT, TET, HAT and HDAC activities were studied using the EpiQuick DNMT 241 
Assay kit (Cat # P-3001-2; Epigentek, Mundolsheim, France), TET Hydroxylase Activity 242 
Quantification kit (Cat # ab156912; Abcam, Cambridge, UK), EpiQuick HAT Assay kit (Cat 243 
# P-4003-96; Epigentek, Mundolsheim, France) and EpiQuick HDAT Assay kit (Cat # P-244 
4002-96; Epigentek, Mundolsheim, France). These assays were performed according to 245 
manufacturer’s instructions. 246 
 247 
Statistical analysis 248 
All data are expressed as means ± standard error of the mean (SEM). Statistical analysis 249 
was carried out using GraphPad Prism6. A direct comparison between a pair of groups was 250 
made using an unpaired Student's t test. P values < 0.05 was considered statistically 251 
significant. 252 
 253 
Results 254 
 255 
Effects of maternal obesity on HF offspring metabolic parameters 256 
Given that metabolic signals including hormonal signaling pathways play critical roles 257 
in determining chromatin structure  (28), we assessed the plasma metabolic profile in HF 258 
offspring. We previously reported that weaned and adult HF offspring exhibited 259 
hyperleptinemia (2, 23). Here, we show that serum triacylglycerol and insulin levels were 260 
elevated in HF male offspring at PND21 (Table 2). At 9 months of age, HF male offspring 261 
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still displayed hyperinsulinemia and had hypercorticosteronemia (2). No difference in plasma 262 
glucose concentration was observed at both stages (Table 2, (2)). 263 
 264 
Offspring from obese dams show persistent decreased PPAR expression levels in 265 
adipose tissue  266 
 At PND21, HF offspring showed a decrease in PPAR mRNA and protein expression 267 
in pWAT and iWAT, consistent with global reduction in PPAR1 and PPAR2 expression 268 
(Fig 1A-D). At 9M, among PPAR1 and PPAR2, only the latter showed a persistent 269 
dowregulation in both fat pads. The impact of maternal obesity on HF offspring's PPAR 270 
target genes was more pronounced in pWAT at both stages, suggesting a depot-specific 271 
programming of adipogenesis and lipogenesis (Fig 1E, F). 272 
 273 
Persistent lower PPAR expression is associated with CpG hypermethylation in the 274 
PPAR2 promoter of HF offspring  275 
We first assessed whether maternal obesity affects CpG methylation status of the 276 
PPAR1 and PPAR2 proximal promoter regions (Fig 2A) in offspring. To do this, we 277 
analyzed single CpG sites by bisulfite pyrosequencing. For the PPAR1 promoter, at PND21, 278 
higher 5mC levels with hypermethylation at two out of seven CpG sites analyzed (-364/-346) 279 
were observed in pWAT of HF offspring (Fig 2B). Only hypermethylation of CpG -346 280 
persisted in HF offspring at 9 months of age (Fig 2B). No variation in DNA methylation 281 
levels were detected in iWAT (Fig 2C). For the PPAR2 promoter, higher 5mC levels were 282 
measured in both fat pads and stages in HF offspring. Two out of four CpG dinucleotides (-283 
215/-199) were similarly affected by maternal obesity. Both CpG were hypermethylated at 284 
PND21 whereas only the CpG -199 remained hypermethylated at 9M (Fig 2D and E). 285 
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Consistently, CpG hypermethylation were correlated with PPAR mRNA levels at PND21 286 
and 9M in both deposits. 287 
 288 
Weaned offspring from obese dams display higher DNMT activity and global DNA 289 
methylation in pWAT 290 
We then assessed whether maternal obesity affects the epigenetic machinery activity in 291 
offspring. At PND21, DNMT activity (Fig 2F) and global DNA methylation (Fig 2G) were 292 
higher in pWAT, consistent with the CpG hypermethylation observed in the PPAR 293 
promoters of HF offspring. No variations in TET activity (Fig 2J) and global 294 
hydroxymethylation (Fig 2K) were observed. No changes of DNMT1, MBD2, MECP2, TET2 295 
and TET3 mRNA levels were detected (Fig S1). No gross modifications were observed in 296 
iWAT at PND21 and in both fat pads at 9M for all parameters (Fig S1). 297 
 298 
Persistent lower PPAR expression is associated with depletion in H3ac/H3K4me3 in the 299 
PPAR2 promoter of HF offspring 300 
 Finally, we assessed whether maternal obesity affects histone modifications in both 301 
promoters of offspring. For the PPAR1 promoter, at PND21, ChIP-qPCR revealed less 302 
enrichment of H3ac and H3K4me3 (active marks) in both fat pads of HF offspring (Fig 3A-303 
F). These differences were no longer observable at 9 months of age (Fig 3A-F). For the 304 
PPAR2 promoter, at PND21, a reduction of active marks H3ac and H3K4me3 and a 305 
tendency towards enrichment of inactive mark H3K9me3 were evidenced only in pWAT of 306 
HF offspring (Fig 3A-F). At 9 months of age, persistent reduction of active mark H3ac was 307 
measured in both fat pads of HF offspring (Fig 3 A-F). No changes in global histone acetyl 308 
transferase and histone deacetylase activities were measured (Fig G and J). No variations of 309 
KAT2, P300, HDAC1, SIRT1, LSD1 and SUV39 mRNA levels were evidenced (Fig S1). 310 
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Discussion 311 
Here, we show, for the first time, that persistent decreased mRNA PPAR2 levels in 312 
adult HF offspring’s WAT may occur via epigenomic remodeling in the PPARγ2 promoter 313 
which take place during lactation.  314 
 We extended our previous work (2) reporting that obesity-prone 9-month-old HF 315 
offspring had lower PPAR2 mRNA expression levels in both pWAT and iWAT fat pads. 316 
Given that PPARγ2 promotes adipocyte differentiation and triglyceride storage in WAT (24), 317 
it may appear paradoxical that maternal obesity reduces PPARγ2 expression in WAT of HF 318 
offspring. However, others have also shown that obesity is associated with a decline in the 319 
PPARγ2 activity and expression (29–32). These modifications appear to be strongly 320 
associated with the pathogenesis of metabolic syndrome (30–32). The decrease in PPARγ2 321 
gene expression might be seen as an adaptive mechanism to prevent further fat accumulation 322 
in WAT (33). It may, in turn, durably change the expression of PPARγ target genes. 323 
Consistent with this hypothesis, recent findings have demonstrated that PPARγ 324 
downregulation in obese mice is associated with a decrease in genome-wide association 325 
occupancy of PPARγ (31).  326 
 We previously reported that HF neonates exhibited a rapid weight gain during lactation. 327 
At PND21, HF male offspring displayed higher iWAT and pWAT deposit weights with 328 
increased leptin mRNA levels, marked adipocyte hypertrophy and hyperplasia. HF 9-month-329 
old male rats showed persistent increased pWAT mass with elevated leptin mRNA levels 330 
whereas this "expandable" phenotype was no longer observed in iWAT (2, 23). By contrast, 331 
both fat pads had persistent lower PPAR expression. These varying outcomes may reflect 332 
difference in postnatal and depot-specific programming. Depot-specific adipogenesis is 333 
regulated by the anatomic location, the unique signature of developmental gene expression 334 
and the hormonal microenvironment of WAT (35). PPAR governs biological processes by 335 
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modifying the expression of a large number of target genes. As already reported (2, 25), gene 336 
expression profiling revealed differences in adipogenic and lipogenic activities between 337 
iWAT and pWAT of adult HF offspring, suggesting a depot-specific programming. It may 338 
appear paradoxical that persistent reduced PPARγ2 expression was correlated with an 339 
increase in expression of genes associated with fat accumulation (i.e., FAS, DGAT2 and LPL) 340 
in pWAT. One possible explanation is that regulation of lipogenic genes in adult HF 341 
offspring’s WAT may occur, at least in part, via additional PPAR-independent signaling 342 
pathways. Consistent with this hypothesis, HF adult male offspring exhibited 343 
hyperinsulinemia with elevated SREBP-1c mRNA levels within pWAT (2) that might be due 344 
for activation of insulin signaling. Indeed, offspring from obese dams showed greater AKT 345 
phosphorylation in response to insulin challenge associated with up-regulation of lipogenic 346 
pathways in WAT (5). 347 
The underlying molecular mechanisms regulating PPAR gene expression remain 348 
unclear. However, decreased PPARγ expression via modifications of epigenetic mechanisms 349 
may play a pivotal role in the development of obesity and diabetes (29, 30, 32, 35–37). Few 350 
studies have shown that DNA methylation and histone modifications regulate the expression 351 
of PPARγ in WAT (32, 35, 36, 38–40). First, during adipogenesis, DNA demethylation (33) 352 
as well as enrichment of active marks H3ac (41) and H3K4me3 (42, 43) were observed in the 353 
PPARγ promoter region that positively regulates gene expression. Second, luciferase reporter 354 
assays demonstrated that PPARγ promoter methylation may repress reporter gene expression 355 
(33). Third, hypermethylation of the PPARγ2 promoter, which was negatively associated with 356 
PPARγ2 expression, was evidenced in visceral WAT of obese animals (32, 36, 38, 40). 357 
However, to our knowledge, no data are available regarding PPARγ programming 358 
mechanisms in offspring from obese dams.  359 
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We showed that PND21 is a period characterized by active epigenomic remodeling (i.e., 360 
higher DNA methylation and lower active histone modification H3ac and H3K4me3) of the 361 
PPARγ2 promoter in pWAT, consistent with decreased PPARγ2 mRNA expression levels. 362 
Higher DNMT activity parallels the increase in global DNA methylation and CpGs 363 
methylation in the PPARγ2 promoter. During lactation, adipocyte stem cells are plastic and 364 
highly sensitive to maternal factors (44). Thus, maternal obesity and modified milk 365 
composition may influence offspring’s nutritional and hormonal status (45, 46). Indeed, 366 
epigenetic enzyme activities are particularly sensitive to intracellular fluctuation in energy as 367 
well as metabolic intermediates (22). In line with this notion, weaned HF offspring exhibited 368 
higher plasma leptin levels (2) as well as insulin and triglycerides concentrations. Consistent 369 
with epigenomic remodeling, global enzyme activity modifications were observed at PND21. 370 
However, the increase in DNMT and DNA methylation activities were restricted to pWAT in 371 
weaned HF offspring. It may rely on spatiotemporal developmental differences that occur 372 
between depots. The DNMT activity is maximal during adipogenesis (47). In rodents, iWAT 373 
depots begin to develop during embryogenesis and the progenitor compartment is established 374 
before the first few days of life whereas pWAT depots mainly develop postnatally during 375 
lactation which coincides with the period of maximum adipogenesis (11, 48). As already 376 
suggested (2, 25), offspring's pWAT seems to be much more sensitive to maternal obesity. 377 
Some of these epigenetic modifications were still observable in the PPARγ2 promoter in 378 
adult HF offspring. Sustained epigenetic modifications (i.e., higher DNA methylation and 379 
lower active histone modification H3ac) were observed in both fat pads of adult HF offspring, 380 
consistent with persistent decreased PPARγ gene expression. 5mC is the only known 381 
modification that targets the DNA itself. In most cases, the extent of 5mC of a promoter is 382 
inversely correlated with the activity of the respective gene (19). We also showed that the 383 
global 5mC level of the PPARγ2 promoter in adult HF offspring was lower than weaned HF 384 
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pups, suggesting that a demethylation process occurs during development of WAT. The 385 
enrichment of H3ac is characteristic of promoter activation (43). A limitation of our work lies 386 
in the fact that DNA analysis was performed on entire tissue without distinguishing adipocyte 387 
and SVF fractions. Extracts may contain different cell type depending on the stage of 388 
development, tissue expansion and physiological states. However, gene expression profiling 389 
using several cell markers suggests that the composition of HF offspring’s WAT is not 390 
modified regardless of the stage of development.  391 
Our results provide compelling evidence that downregulation of PPARγ expression may 392 
have developmental origins through epigenetic mechanisms. Thus, editing of early-life 393 
epigenetic markings that occurs during development of WAT may persist throughout life. 394 
Consistent with the DOHaD hypothesis, retained marks may provide a mechanistic basis for 395 
the cellular “memory” linking maternal obesity to a predisposition for later adiposity. 396 
 397 
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Table 1 576 
Primers used for RT-qPCR and pyrosequencing. Primer sequences are indicated (see text for 577 
definitions). 578 
 579 
 580 
 581 
 582 
 583 
 584 
Targeted mRNA Targeted regions
Forward TTGGCCATATTTATAGCTGTCATTATT Forward ATGTTGGTTAAATGAGTTTATTTAGTG
Reverse TGTCCTGGATGGGCTTCA Reverse Biotin- ACACTATCCTAATTAAAAACCAACTA
Forward GCACTGCCTATGAGCACTTC Sequence ATTGAATGTGTGGG
Reverse GTGGCCTGTTGTAGAGTTGG Forward TTGTTTAGTTTTGTGGAATGTGGAGAGTAG
Forward GCTGCAGCGCTAAATTCATC Reverse Biotin- ACTATCTCCCCAATAACCCACACATTCA
Reverse GCTGATTCCGAAGTTGGTGG Sequence TGTTGAATA-AATTATTTTAGAAGT
Forward CCAATCACGCAATAGTTCTGG Forward GGGGGATTATTGTTATGTGATATGTT
Reverse CGCTGTATCGTATGGCGAT Reverse Biotin -ATAAAAAAAATTAAAACCCTCCCTAAAAAT
Forward CAGGAGATGCTGGAATGACA Sequence ATTAGGTTATTTATGTGATAAGG
Reverse CTACGCTGAATGCTGAGTGAT Forward AACTATCACCAAATCCACACAAT
Forward TGCATGAATTAGTTGAACCAGGCCA Reverse Biotin- CCCAAAACAATCTAACACCAACCATAA
Reverse CCACAGTTCCGATCGCAGCCC Sequence 1 GGTTTTTTTAGAAGGTGTT
Forward AGTTGACCAGTGACAATGACCG Sequence 2 GTGAGAGTTAGGAGTAGGGTA
Reverse TCAGGCAGCTGGCGGAAG Sequence 3 TTTGATAGGAAAGTTAGGT
Forward AGGCCTTGATGGTTTCTATCCA Targeted regions
Reverse GCTGCCCTTCCCCAATTAAC Forward ACAGTTTTCAGAGAGGGGCT
Forward TAGTTCGGTGGCTACGAGGA Reverse CGACAGTGACCCCATTTTCC
Reverse CGTTTAGCGGGACCCTTGAA Forward ACAGTTCACACCCCTCACAA
Forward GACCTGGAAACTCGTCTCCA Reverse TGGCACTGTCCTGATTGAGA
Reverse CATACCGGCCACTTTCCTGG Forward AGAGCTGAAAGAGGGCAAGA
Forward GGACATGGTCACAGACGATGAC Reverse GTCTCTCCTGCCCTCAAACT
Reverse GTCGAACTTGGACAGATCCTTCA Forward CAGGCTGTTGAGTGGGTAGA
Forward AGGCACCCTCACTACCCTTT Reverse GGGCCACTGTTGCCATTTTA
Reverse ATAGCCCTTTTCCTTCCCAA
Forward CCAGAAGCCAAAGGGGTCAA
Reverse TGCGCTGGTCCCTATCTAGT
Forward ACTCCCATCTTCAGTCCTTC
Reverse CTTCCTCCTCTCTCCTGGC
Forward AAGGTCATCTTCTGTGCCA
Reverse CAGCCCGACTTCTTCAGAGA
Forward GGCAAGAGCGATGTCTACTA
Reverse CTGGACCGACTCCTTGAAGA
Forward CAGCTCCAACAGGATTCCATGGT
Reverse TGATGTCTCTGCTTTGCCTGCCT
Forward AGATTCAGAGGGCAGCAGAGAC
Reverse GCCATAGGAGGTGGGTTCATAC
Forward AGACTTCAGCTCCCTACTG
Reverse CTAGTGACGGTTGTGCCTT
Forward CTGTTTCCTGTGGGATACCTGACT
Reverse ATCGAACATGGCTTGAGGATC T
Forward CATCGACTACATCCGCTTCTTACA
Reverse GTCTTTCAGTGATTTGCTTTTGTGA
Forward AATCGCCTTCGGATTCAGACACTC
Reverse CTTGACCTCCGATACACCCAT T
Forward TCAGCAACACCTTCATCACAA
Reverse TTTTCCTTGGGTGGTTTGTCA
Forward ATTCATGTGCCAGGGTGGT
Reverse GATGCCAGGACCTGTATGCT
Forward GACGGTCACGGAGGATAAGATC
Reverse GCAAACAAGCCAGGCCAGAAA
ChIP-qPCR primer sequences
PPARγ1 promoter
PPARγ2 promoter
Control A
Control B
Pyrosequencing primer sequences
PPARγ2 promoter 
#1
PPARγ2 promoter 
#2
PPARγ2 promoter 
#3
PPARγ1 promoter 
#1
RT-qPCR primer sequences
PPARγ
Ppia
Rplp1
CD36
HDAC1
LPL
MBD2
SREBP1
KAT2A
TET2
TET3
MeCP2
P300
PPARγ1
PPARγ2
Resistin
Sirt1
Acox
AdipoQ
C/EBP α
DGAT2
DNMT1
FABP4
FAS
GLUT4
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Table 2 585 
Plasma parameters of weaned male offspring from obese dams fed either a control (C) or a 586 
high-fat (HF) diet 587 
 588 
 589 
 590 
All data are presented as means +/- SEM. Data were analyzed using Student’s t test. Effects of 591 
maternal obesity at PND21 (*P  0.05). n = 20 per group. 592 
 593 
 594 
 595 
 596 
 597 
 598 
 599 
 600 
 601 
 602 
Variable
C HF
Maternal 
diet effect              
p value
Glucose (dg/ml) 168.22 ± 5.49 171.14 ± 2.54 ns
Triacyglycerol(mg/dl) 210.9 ± 11.28 281.9 ± 13.10 *
Insulin (µU/ml) 34.35 ± 5.94 60.99 ± 5.49 *
Corticosterone (ng/ml) 221.21 ± 16.87 216.63 ± 20.84 ns
Male Offspring PND21
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Figure legends 603 
 604 
Figure 1: Maternal obesity induces persistent lower PPAR expression in adipose tissue 605 
of offspring 606 
 PPAR expression was assessed in male offspring from dams fed a control diet (called 607 
C) or high-fat diet-fed dams (called HF) on postnatal days 21 (PND21) and 9 months of age 608 
(9M). PPAR, PPAR1 and PPAR2 mRNA levels were determined in pWAT (A) and iWAT 609 
(B) by RT-qPCR. Representative Western blot of PPAR (55 KDa) and -Actin (43 KDa) 610 
were indicated in pWAT (C) and iWAT (D). mRNA levels of PPAR target genes were 611 
determined in pWAT (E) and iWAT (F) by RT-qPCR. Relative gene expression in the C 612 
group at PND21 was set to 1. Ppia and Rplp1 were used as standard genes. All data are 613 
presented as means +/- SEM. Data were analyzed using Student’s t test. Effects of maternal 614 
obesity at PND21 (*P  0.05) and at 9M (#P  0.05). n = 5-10 per group. 615 
 616 
Figure 2:  Persistent lower PPAR expression is associated with CpG hypermethylation 617 
in the PPAR2 promoter of HF offspring 618 
 Epigenetic modifications were assessed in male C and HF offspring in two fat pads 619 
(pWAT and iWAT) at PND21 and 9M. Schematic positions and sequences of rat PPAR1 and 620 
PPAR2 promoters were shown (A). CpG methylation in PPAR1 promoter (B, C) and 621 
PPAR2 promoter (D, E) were assessed by bisulfite pyrosequencing in pWAT (B, D) and 622 
iWAT (C, E). DNMT activity from nuclear protein (F) and global DNA methylation (G) 623 
were assessed in pWAT and iWAT. TET activity from nuclear protein (H) and global DNA 624 
hydroxymethylation (I) were assessed in pWAT and iWAT. All data are presented as means 625 
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+/- SEM. Data were analyzed using Student’s t test. Effects of maternal obesity at PND21 (*P 626 
 0.05) and at 9M (# 0.05). n = 5 per group. 627 
 628 
Figure 3: Persistent lower PPAR expression is associated with depletion in 629 
H3ac/H3K4me3 in the PPAR2 promoter of HF offspring 630 
 Epigenetic modifications were assessed in male C and HF offspring in two fat pads 631 
(pWAT and iWAT) at PND21 and 9M. Histone modifications were measured by ChIP assays 632 
with antibodies against H3ac (A, B), H3K4me3 (active mark) (C, D) and H3K9me3 (inactive 633 
mark) (E, F) in pWAT (A, C, E) and iWAT (B, D, F). HAT (G) and HDAC (H) activities 634 
were assessed from nuclear protein of pWAT and iWAT. All data are presented as means +/- 635 
SEM. Data were analyzed using Student’s t test. Effects of maternal obesity at PND21 (*P  636 
0.05) and at 9M (#P  0.05). n = 5 per group. 637 
 638 
 639 
 640 
 641 
 642 
 643 
(arbitrary units) (arbitrary units) 
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